factually
Index/Topics/Blood Biomarkers for Alzheimer's Disease

Blood Biomarkers for Alzheimer's Disease

The development and validation of blood biomarkers, such as p-tau and Aβ ratios, for diagnosing Alzheimer's disease.

Fact-Checks

2 results
Jan 23, 2026
Most Viewed

How do amyloid PET and CSF biomarker tests influence eligibility for FDA‑approved Alzheimer’s therapies?

‑approved anti‑amyloid therapies for early symptomatic Alzheimer’s disease require evidence of brain amyloid pathology before initiation, and clinicians most commonly rely on amyloid PET imaging or ce...

Feb 4, 2026

Have randomized trials tested whether changing sleep position alters amyloid or tau levels in humans?

No randomized trials have directly tested whether changing (for example, supine versus lateral) alters amyloid or tau levels in humans; the randomized human experiments reported in the scientific lite...